40 related articles for article (PubMed ID: 17549364)
1. The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation.
Westhoff CL; Guo H; Wang Z; Hibshoosh H; Polaneczky M; Pike MC; Ha R
Breast Cancer Res Treat; 2022 Apr; 192(2):321-329. PubMed ID: 35015210
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland.
Ranjan M; Lee O; Cottone G; Mirzaei Mehrabad E; Spike BT; Zeng Z; Yadav S; Chatterton R; Kim JJ; Clare SE; Khan SA
Breast Cancer Res; 2021 Aug; 23(1):78. PubMed ID: 34344445
[TBL] [Abstract][Full Text] [Related]
3. Classical and Non-Classical Progesterone Signaling in Breast Cancers.
Pedroza DA; Subramani R; Lakshmanaswamy R
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867363
[TBL] [Abstract][Full Text] [Related]
4. Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.
Islam MS; Afrin S; Jones SI; Segars J
Endocr Rev; 2020 Oct; 41(5):. PubMed ID: 32365199
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
6. Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products.
Dean M; Murphy BT; Burdette JE
Mol Cell Endocrinol; 2017 Feb; 442():98-105. PubMed ID: 27986590
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model.
Esber N; Cherbonnier C; Resche-Rigon M; Hamze A; Alami M; Fagart J; Loosfelt H; Lombès M; Chabbert-Buffet N
Horm Cancer; 2016 Apr; 7(2):137-47. PubMed ID: 26941094
[TBL] [Abstract][Full Text] [Related]
8. Antiprogestins in gynecological diseases.
Goyeneche AA; Telleria CM
Reproduction; 2015 Jan; 149(1):R15-33. PubMed ID: 25252652
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124.
Uphouse L; Hiegel C
Pharmacol Biochem Behav; 2014 Jul; 122():16-9. PubMed ID: 24650591
[TBL] [Abstract][Full Text] [Related]
10. An antiprogestin, CDB4124, blocks progesterone's attenuation of the negative effects of a mild stress on sexual behavior.
Uphouse L; Hiegel C
Behav Brain Res; 2013 Mar; 240():21-5. PubMed ID: 23153933
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim.
Periyasamy-Thandavan S; Takhar S; Singer A; Dohn MR; Jackson WH; Welborn AE; LeRoith D; Marrero M; Thangaraju M; Huang S; Schoenlein PV
Breast Cancer Res; 2012 Mar; 14(2):R52. PubMed ID: 22429491
[TBL] [Abstract][Full Text] [Related]
12. The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.
Yuan H; Upadhyay G; Lu J; Kopelovich L; Glazer RI
Cancer Prev Res (Phila); 2012 May; 5(5):754-64. PubMed ID: 22427346
[TBL] [Abstract][Full Text] [Related]
13. Progesterone inhibits the growth of human neuroblastoma: in vitro and in vivo evidence.
Atif F; Sayeed I; Yousuf S; Ishrat T; Hua F; Wang J; Brat DJ; Stein DG
Mol Med; 2011; 17(9-10):1084-94. PubMed ID: 21695351
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2.
Goyeneche AA; Seidel EE; Telleria CM
Invest New Drugs; 2012 Jun; 30(3):967-80. PubMed ID: 21424700
[TBL] [Abstract][Full Text] [Related]
15. Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: comparison between RU486 and a new 21-substituted-19-nor-progestin.
Wiehle RD; Christov K; Mehta R
Oncol Rep; 2007 Jul; 18(1):167-74. PubMed ID: 17549364
[TBL] [Abstract][Full Text] [Related]
16. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Lee O; Choi MR; Christov K; Ivancic D; Khan SA
Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
[TBL] [Abstract][Full Text] [Related]
18. CDB-4124, a progesterone receptor modulator, inhibits mammary carcinogenesis by suppressing cell proliferation and inducing apoptosis.
Wiehle R; Lantvit D; Yamada T; Christov K
Cancer Prev Res (Phila); 2011 Mar; 4(3):414-24. PubMed ID: 21119048
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
